Article Details

FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC

Retrieved on: 2025-10-02 21:03:43

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC. View article details on hiswai:

Excerpt

Monoclonal antibodies are used to treat lung cancer. They are created in a lab and. Extensive-stage small cell lung cancer can appear in 30,000 ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo